Pyxis Oncology names Thomas Civik CEO, chairman
Pyxis Oncology appointed Thomas Civik as permanent chief executive officer and chairman, effective September 4, 2026. John Flavin becomes lead independent director and compensation committee chair.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.